不确定潜力的克隆造血:一个多系统的枢纽,将造血功能障碍与非造血性疾病联系起来
Jing-Lei Zhang1,2, Shuo-Lan Tong2,3, Qi-Qi Zhuang2,3
1Department of Oncology, Affiliated Hospital of Shandong Second Medical University, Shandong Second Medical University, Weifang, 261042, Shandong, China.
Military Medical Research
|October 15, 2025
概括
不确定潜力的克隆性血液形成 (CHIP) 与慢性炎症和非血液性疾病有关. 了解其遗传驱动因素和影响对于诊断和向治疗至关重要.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 遗传学 是一个遗传学.
背景情况:
- 不确定潜力的克隆性血液形成 (CHIP) 产生于血液形成干细胞的体性突变.
- CHIP主要被认为是血液性恶性瘤的危险因素.
- 新出现的证据将CHIP与慢性炎症和非血液学疾病联系起来.
研究的目的:
- 审查CHIP在非血液性疾病中的作用的机制性见解和临床证据.
- 讨论CHIP相关突变 (DNMT3A,TET2,ASXL1) 对表观遗传程序和炎症的影响.
- 探索CHIP对固体瘤,心血管,代谢,脏和神经退行性疾病的影响.
主要方法:
- 文献综述,整合机理学研究和临床证据.
- 分析CHIP相关突变 (DNMT3A,TET2,ASXL1) 和它们的影响.
- 讨论诊断和治疗方面的影响.
主要成果:
- CHIP突变改变了表观遗传程序,歪曲了骨髓形成,并增加了促炎细胞因子.
- CHIP与慢性炎症,免疫失衡以及各种非血液性疾病有关.
- CHIP在固体瘤,心血管疾病,代谢失调,功能障碍和神经退行症中起作用.
结论:
- CHIP是慢性炎症和各种非血液性疾病的重要危险因素.
- 对于CHIP,需要特定于突变的诊断方法.
- 为CHIP管理,建议以遗传特征为指导的定制治疗干预措施.
相关概念视频
Multipotency of Hematopoietic Stem Cells
3.8K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.8K
Hematopoiesis
8.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
8.7K
Lineage Commitment
4.1K
Commitment is the process whereby stem cells:
4.1K
Production of Formed Elements
3.6K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
3.6K
Regulation of Hematopoietic Stem Cells
4.0K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K
Overview of Hematopoiesis
8.3K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
8.3K


